临床合理用药2025,Vol.18Issue(23) :4-7.DOI:10.15887/j.cnki.13-1389/r.2025.23.002

骨疏康胶囊联合阿仑膦酸钠及二甲双胍治疗骨质疏松合并2型糖尿病的临床疗效

Clinical effect of Gushukang capsules combined with alendronate sodium and metformin in the treatment of osteopo-rosis complicated with type 2 diabetes mellitus

王瑒 郭莉 范瑞琪 严梅娣
临床合理用药2025,Vol.18Issue(23) :4-7.DOI:10.15887/j.cnki.13-1389/r.2025.23.002

骨疏康胶囊联合阿仑膦酸钠及二甲双胍治疗骨质疏松合并2型糖尿病的临床疗效

Clinical effect of Gushukang capsules combined with alendronate sodium and metformin in the treatment of osteopo-rosis complicated with type 2 diabetes mellitus

王瑒 1郭莉 1范瑞琪 1严梅娣2
扫码查看

作者信息

  • 1. 341000 江西省赣州市,赣南医科大学第一附属医院
  • 2. 342200 江西省寻乌县中医院
  • 折叠

摘要

目的 观察骨疏康胶囊联合阿仑膦酸钠及二甲双胍治疗骨质疏松合并2型糖尿病的临床疗效.方法 选取2024年1-12月于赣南医科大学第一附属医院就诊的骨质疏松合并2型糖尿病女性患者48例,按随机数字表法分为联合组和对照组,各24例.2组均给予生活方式干预、钙剂、维生素D及阿卡波糖治疗,对照组在此基础上给予阿仑膦酸钠+二甲双胍治疗,联合组在对照组基础上加用骨疏康胶囊治疗,2组均治疗6个月.比较2组治疗前及治疗3、6个月后血糖指标[空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)]、骨代谢指标[Ⅰ型胶原氨基端延长肽(PⅠNP)、β-胶原特殊序列(β-CTx)],治疗前及治疗6个月后骨密度.结果 治疗3、6个月后,2组FPG、2 hPG、HbA1c水平低于治疗前(P<0.05),组间比较差异无统计学意义(P>0.05).治疗3个月后,2组血清P Ⅰ NP、β-CTx水平低于治疗前,且联合组P Ⅰ NP水平低于同期对照组(P<0.05),2组β-CTx水平比较差异无统计学意义(P>0.05);治疗6个月后,2组血清P Ⅰ NP、β-CTx水平低于治疗前及治疗3个月,且联合组低于同期对照组(P<0.05).治疗6个月后,2组左侧股骨颈、第1~4腰椎骨密度高于治疗前,且联合组高于对照组(P<0.05或P<0.01).结论 骨疏康胶囊联合阿仑膦酸钠及二甲双胍治疗骨质疏松合并2型糖尿病的临床效果较好,有利于控制血糖,改善骨代谢,增加骨密度.

Abstract

Objective To observe the clinical effect of Gushukang capsules combined with alendronate sodium and metformin in the treatment of osteoporosis combined with type 2 diabetes mellitus.Methods A total of 48 female patients with osteoporosis and type 2 diabetes mellitus who were treated in the First Affiliated Hospital of Gannan Medical University from January to December 2024 were selected and divided into the combined group and the control group according to the ran-dom number table method,with 24 cases in each group.Both groups were given lifestyle intervention,calcium,vitamin D and acarbose treatment,the control group was treated with alendronate sodium and metformin on the basis of the treatment,and the combined group was treated with Gushukang capsules on the basis of the control group.Both groups were treated for 6 months.The blood glucose indexes(FPG,2 hPG,HbA1c)and bone metabolism indexes(PⅠNP,β-CTx)before treatment and 3,6 months after treatment,and bone mineral density before treatment and after 6 months of treatment were compared between the two groups.Results After 3 and 6 months of treatment,the levels of FPG,2 hPG and HbA1c in the two groups were lower than those before treatment(P<0.05),and there were no significant differences between the two groups(P>0.05).After 3 months of treatment,the levels of serum PⅠNP and β-CTx in the two groups were lower than those before treatment,and the level of PⅠNP in the combined group was lower than that in the control group(P<0.05),and there was no significant difference in the level of β-CTx between the two groups(P>0.05).After 6 months of treatment,the serum levels of PⅠNP and β-CTx in the two groups were lower than those before treatment and 3 months of treatment,and those in the combined group were lower than those in the control group during the same period(P<0.05).After 6 months of treatment,the bone mineral density of left femoral neck and 1st to 4th lumbar vertebrae in the two groups were higher than those before treatment,and those in the combined group were higher than those in the control group(P<0.05 or P<0.01).Conclusion The clinical effect of Gushukang capsules combined with alendronate sodium and metformin in the treatment of osteoporosis combined with type 2 diabetes is better,which is beneficial to control blood glucose,improve bone metabolism,and increase bone mineral density.

关键词

骨质疏松/2型糖尿病/骨疏康胶囊/阿仑膦酸钠/二甲双胍/骨代谢

Key words

Osteoporosis/Type 2 diabetes mellitus/Gushukang capsules/Alendronate sodium/Metformin/Bone me-tabolism

引用本文复制引用

出版年

2025
临床合理用药
河北省科学技术协会

临床合理用药

影响因子:0.799
ISSN:1374-3296
段落导航相关论文